2015
Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system
Springer SA, Brown SE, Di Paola A, Altice FL. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug And Alcohol Dependence 2015, 157: 158-165. PMID: 26560326, PMCID: PMC4675147, DOI: 10.1016/j.drugalcdep.2015.10.023.Peer-Reviewed Original ResearchConceptsAlcohol use disorderExtended-release naltrexoneOpioid use disorderXR-NTXUse disordersHIV diseaseFirst injectionDouble-blind placebo-controlled randomized trialSecond injectionPlacebo-controlled randomized trialSubstance use disordersMultivariate regression analysisTreatment of alcoholCorrelates of retentionAntiretroviral therapyStudy drugHIV infectionRandomized trialsUrine testsUrine screensEligible personsDays of releaseHazardous drinkingCocaine useDemographic features
1998
Predictors of HIV Infection Among Newly Sentenced Male Prisoners
Altice F, Mostashari F, Selwyn P, Checko P, Singh R, Tanguay S, Blanchette E. Predictors of HIV Infection Among Newly Sentenced Male Prisoners. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: 444-453. PMID: 9715840, DOI: 10.1097/00042560-199808150-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsBlood TransfusionConfounding Factors, EpidemiologicConnecticutEmergency Medical ServicesForecastingHematologic DiseasesHepatitis, Viral, HumanHIV AntibodiesHIV SeropositivityHIV-1HumansMaleMental DisordersPrevalencePrimary Health CarePrisonersRisk FactorsSexual BehaviorSexually Transmitted DiseasesSubstance Abuse, IntravenousTuberculosisWounds, GunshotConceptsHIV infectionAppropriate risk-reduction interventionsPotent combination antiretroviral therapyElevated aspartate aminotransferase levelsSelf-reported high-risk behaviorsHIV testing resourcesCombination antiretroviral therapyHIV-seropositive personsInjection drug useAspartate aminotransferase levelsAge-adjusted ratesRisk reduction interventionsMultivariate regression analysisHigh-risk behaviorsPrevalence of individualsComprehensive HIVAntiretroviral therapyHIV careAminotransferase levelsHIV serosurveyIndependent predictorsLaboratory markersHIV statusHIV prevalenceBlack race